Kellie L. Jones, PharmD, BCOP Clinical Associate Professor of Pharmacy Practice Phone: (317) 278-5331 E-mail: kjones14@clarian.org Full directory listing

Education

Research

Identifying tools to better assess patient disease related symptoms; Optimizing patient education; Evaluating the tolerability/feasibility of intraperitoneal chemotherapy; Evaluating complementary/alternative medicine use in cancer patients

Interests

Pain management, patient education, utilization of growth factors, cancer treatment related symptoms, and complementary/alternative medicines.

Honors and Credentials

Board Certified Oncology Pharmacist

Clinical Practice

Indiana University Simon Cancer Center

Representative Publications

Jones, KL. Metastatic Breast Cancer Chapter. Pharmacotherapy Self-Assesment Program. Sixth Edition, Book 10, 2009.

Jones, KL, Kiel, P. Drug Induced Thrombocytopenia. Drug Induced Disease: Prevention, Detection, and Management. Second Edition. In press.

Barnett C, Gauthier M, Jones KL, Boster B, Espirito J, Michaud L. Clinical Outcomes of a Pharmacist Managed Anticoagulation Service for Breast Cancer Patients. J Oncol Pharm Pract. 2008;14(2):85.

Mach C, Jones KL, Hunter R, Burns KA, Kurian S, Webb N, Munsell M, Brown J, Smith JA. Evaluation of the addition of premedications prior to carboplatin to prevent hypersensitivity reactions in ovarian cancer patients. J Oncol Pharm Pract. 2008;14(4):200.

Mach C, Jones KL, Wolf JK, Munsell M, Smith JA. Evaluation of residual toxicity and time to recurrence following intraperitoneal chemotherapy for the treatment of ovarian cancer. J Oncol Pharm Pract. 2008;14(4):201.

Jones KL, Saucier J, Sun C, Bevers M, Ramondetta L, Brown J, Smith JA. Comparison of Chemotherapy Education and Patient Preferences in Community Versus Academic Gynecology Oncology Clinics. J Oncol Pharm Pract. 2008;14(1):31-6.

Jones KL. Chapter 2: Ovarian Ablation. In: Buzdar AU, ed. Endocrine Therapies in Breast Cancer. Oxford University Press; New York. 2007;pg 13-27.

Michaud LB, Karpinski JP, Jones KL, Espirito J. Dietary supplements in patients with cancer: risks and key concepts, part 1: Am J Health Syst Pharm. 2007;64:369-81.

Michaud LB, Karpinski JP, Jones KL, Espirito J. Dietary supplements in patients with cancer:risks and key concepts, part 2. Am J Health Syst Pharm. 2007;64:467-80.

Jones KL, Buzdar AU. Trastuzumab in the treatment of early breast cancer. Breast Diseases A Year Book Quarterly. 2006;17(1):19-22.